VIPR2 Protein (AA 24-126) (mFc Tag)

Produktnummer ABIN7504562

Produktdetails

Target: VIPR2 (Vasoactive Intestinal Peptide Receptor 2 (VIPR2))

Protein-Typ: Recombinant

Proteineigenschaft: AA 24-126

Spezies: Human

Quelle: HEK-293 Cells

Aufreinigungstag / Konjugat: Dieses VIPR2 Protein ist gelabelt mit mFc Tag.

Verwendungszweck: Human VIPR2 Protein

Sequenz: Glu24-Val126

Produktmerkmale: Recombinant Human VIPR2 Protein is expressed from HEK293 with mFc tag at the C-terminus.It contains Glu24-Val126.

Reinheit: > 95 % as determined by Tris-Bis PAGE,> 95 % as determined by HPLC

Sterilität: 0.22 μm filtered

Endotoxin-Niveau: Less than 1EU per μg by the LAL method.

Anwendungsinformationen

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Lyophilized

Rekonstitution: Centrifuge the tube before opening. Reconstituting to a concentration more than 100 μg/mL is recommended. Dissolve the lyophilized protein in distilled water.

Buffer: Lyophilized from 0.22 μm filtered solution in PBS ( pH 7.4). Normally 8 % trehalose is added as protectant before lyophilization.

Lagerung: -20 °C,-80 °C

Informationen zur Lagerung: -20 to -80°C for 12 months as supplied from date of receipt., -80°C for 3-6 months after reconstitution., 2-8°C for 2-7 days after reconstitution., Recommend to aliquot the protein into smaller quantities for optimal storage. Please minimize freeze-thaw cycles.

Haltbarkeit: 12 months

Antigendetails

Target: VIPR2 (Vasoactive Intestinal Peptide Receptor 2 (VIPR2))

Andere Bezeichnung: VIPR2 (VIPR2 Produkte)

Synonyme: C16DUPq36.3 Protein, DUP7q36.3 Protein, PACAP-R-3 Protein, PACAP-R3 Protein, VIP-R-2 Protein, VPAC2 Protein, VPAC2R Protein, VPCAP2R Protein, VIPR2 Protein, LOC100136266 Protein, Vip2 Protein, pacap Protein, vpac2 Protein, vpac2-R Protein, vpac2-r Protein, vpcap2r Protein, LOC100229999 Protein, vasoactive intestinal peptide receptor 2 Protein, vasoactive intestinal polypeptide receptor type 2 Protein, VIPR2 Protein, LOC100136266 Protein, Vipr2 Protein, vipr2 Protein

Hintergrund: Effects of vasoactive intestinal peptide (VIP) on T cell migration are mediated by structurally distinct types I (VIPR1) and II (VIPR2) G protein-associated receptors. The two receptor types were proposed to transduce opposite effects on human T cells, since cytokine-induced chemotaxis of VIPR1-bearing HuT 78 human T cells, in contrast to T cells that express VIPR2, was inhibited by VIP.

Molekulargewicht: 37.35 kDa. Due to glycosylation, the protein migrates to 45-60 kDa based on Tris-Bis PAGE result.

Pathways: cAMP Metabolic Process